Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : INCY    crawled date : 2021 - 04 - 06    save search

Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Published: 2021-04-06 (Crawled : 23:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.51% C: -1.02%
INCY | $52.3 -0.98% -0.99% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 1.07% C: 0.22%

new drug treatment dermatitis drug baricitinib atopic dermatitis
Gainers vs Losers
67% 33%

Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K twitter stocktwits trandingview |
Energy Minerals

KUKE | $2.88 2.49% 7.64% 360K twitter stocktwits trandingview |

MPLN | $0.6502 -11.74% 4.51% 2.2M twitter stocktwits trandingview |
Finance

CXM 4 | $11.34 -0.44% 4.27% 1.7M twitter stocktwits trandingview |
Information

PVL 4 | $1.47 -0.68% 4.08% 77K twitter stocktwits trandingview |
Energy Minerals

OUST 4 | $7.16 2.43% 3.77% 880K twitter stocktwits trandingview |
Manufacturing

RNR 4 | $224.74 0.85% 3.52% 310K twitter stocktwits trandingview |
Finance

PZG | $0.4431 0.48% 2.91% 150K twitter stocktwits trandingview |
Non-Energy Minerals

LEV | $0.972 0.73% 2.88% 570K twitter stocktwits trandingview |
Manufacturing

AJX 4 | $3.47 2.06% 2.02% 110K twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.